Effects of intracerebroventricular losartan on angiotensin II-mediated pressor responses and c-fos expression in near-term ovine fetus

Journal of Comparative Neurology

Volumn 493, Issue 4, 2005, Pages 571-579

  Shi, Lijun ^b   Mao, Caiping ^a   Thornton, Simon N ^c   Sun, Wanping ^a   Wu, Jiawei ^a   Yao, Jiaming ^b   Xu, Zhice ^a,b,d  

^a MEDICAL COLLEGE OF SOOCHOW UNIVERSITY   (China)

^b HARBOR UCLA MEDICAL CENTER   (United States)

^c UNIVERSITÉ DE LORRAINE   (France)

^d NONE   (United States)

Author keywords

Blood pressure; Brain; c fos; Fetal development; Losartan

Indexed keywords

1 (4 DIMETHYLAMINO 3 METHYLBENZYL) 5 DIPHENYLACETYL 4,5,6,7 TETRAHYDRO 1H IMIDAZO[4,5 C]PYRIDINE 6 CARBOXYLIC ACID; ANGIOTENSIN; ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN ANTAGONIST; LOSARTAN;

ARTICLE; BRADYCARDIA; CARDIOVASCULAR RESPONSE; CONTROLLED STUDY; DRUG MECHANISM; DRUG MEGADOSE; FETUS; FETUS DEVELOPMENT; GESTATIONAL AGE; MEDIAL PREOPTIC AREA; NONHUMAN; ONCOGENE C FOS; PRESSOR RESPONSE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REGULATORY MECHANISM; RELIABILITY; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RHOMBENCEPHALON; SHEEP; SOLITARY TRACT NUCLEUS; THALAMUS MIDLINE NUCLEUS;

ANALYSIS OF VARIANCE; ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; FETUS; GENES, FOS; GESTATIONAL AGE; HOMEOSTASIS; INJECTIONS, INTRAVENTRICULAR; LOSARTAN; PREGNANCY; PROSENCEPHALON; SHEEP; STATISTICS, NONPARAMETRIC;

EID: 28844437288     PISSN: 00219967     EISSN: None     Source Type: Journal    
DOI: 10.1002/cne.20802     Document Type: Article

References (53)

1. Andreatta SH, Averill DL, Santos RAS, Ferrario CM. 1988. The ventrolateral medulla: a new site of action of the renin-angiotensin system. Hypertension 11:1163-1166.
2. Averill DB, Diz DI. 2000. Angiotensin peptides and the baroreflex control of sympathetic outflow: pathways and mechanisms of the medulla oblongata. Brain Res Bull 51:119-128.
3. Blessing WW, Reis DJ. 1982. Inhibitory cardiovascular function of neurons in the caudal ventrolateral medulla of the rabbit: relationship to the area containing A1 noradrenergic cells. Brain Res 253:161-171.
4. Bumpus FM, Catt KJ, Chiu AT, de Gasparo M, Goodfriend T, Husain A, Peach MJ, Taylor DG, Timmermans PBMWM. 1991. Nomenclature for angiotensin receptors. Hypertension 17:720-721.
5. Bunting MW, Widdop RE. 1995. Lack of a centrally-mediated antihypertensive effect following acute or chronic central treatment with AT1-receptor antagonists in spontaneously hypertensive rats. Br J Pharmacol 116:3181-3190.
6. 2 angiotensin receptor subtype predominates in the 18 day gestation fetal rat brain. Brain Res 560:334-336.
7. De Gasparo M, Catt KJ, Inagami T, Wright JW, Unger TH. 2000. Inter-national Union of Pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52:415-472.
8. De Luca LA Jr, Barbosa SP, Menani JV, Camargo LAA, Saad WA, Renzi A. 1994. Different effects on rat arterial pressure and heart rate when losartan is injected into the third or fourth ventricle. Braz J Med Biol Res 27:2681-2687.
9. De Luca LA Jr, Barbosa SP, Sugawara AM, Menani JV. 1996. Effects of intracerebroventricular injections of losartan or PD123319 on arterial pressure and heart rate of sodium replete and sodium deplete rats. Regul Pept 66:31-35.
10. De Luca LA Jr, Sugawara AM, Menani JV. 2000. Brain versus peripheral angiotensin II receptors in hypovolaemia: behavioral and cardiovascular implications. Clin Exp Pharmacol Physiol 27:437-442.
11. Dudley DT, Panek RL, Major TC, Lu GH, Burns RF, Klinkefus BA, Hodges JC, Weishaar RE. 1990. Subclasses of angiotensin II binding sites and their functional significance. Mol Pharmacol 38:370-377.
12. Feldberg W, Guertzenstein PG. 1976. Vasodepressor effects obtained by drugs acting on the ventral surface of the brain stem. J Physiol 258: 337-355.
13. Fitzsimons JT. 1998. Angiotensin, thirst, and sodium appetite. Physiol Rev 78:583-686.
14. Fontes MA, Finge MC, Naves V, Campagnole-Santos MJ, Lopes OU, Khosla MC, Santos RA. 1997. Cardiovascular effects produced by microinjection of angiotensins and angiotensin antagonists into the ventrolateral medulla of freely moving rats. Brain Res 750:305-310.
15. Fow JE, Averill DB, Barnes KL. 1994. Mechanisms of angiotensin-induced hypotension and bradycardia in the medial solitary tract nucleus. Am J Physiol 267:H259-H266.
16. Gaudet EA, Godwin SJ, Head GA. 1988. Role of central catecholaminergic pathways in the actions of endogenous Ang II on sympathetic reflexes. Am J Physiol 275:R1174-R1184.
17. Lark LA, Wappel SM, Weyhenmeyer JA. 1995. Cardiovascular effects after the intracerebroventricular administration of peptide and nonpeptide angiotensin antagonists in Dah1 salts-sensitive rats. J Pharmacol Exp Ther 274:745-751.
18. Lenkei Z, Palkovits M, Corvol P, Llorens-Cortes C. 1998. Distribution of angiotensin type-1 receptor messenger RNA expression in the adult rat brain. Neuroscience 82:827-841.
19. Mathai ML, Evered MD, McKinley MJ. 1998. Central losartan blocks natriuretic, vasopressin, and pressor responses to central hypertonic NaCl in sheep. Am J Physiol 275:R548-R554.
20. McKinley MJ, McBurnie MI, Mathai ML. 2001. Neural mechanisms subserving central angiotensinergic influences on plasma renin in sheep. Hypertension 37:1375-1381.
21. Mousseau M-C, Thornton SN, Martial FP, Lienard F, Nicolaidis S. 1996. Neural responses to iontophoretically applied angiotensin II, losartan and aldosterone, as well as gustatory stimuli, in non-anesthetized control and deoxycorticisterone acetate-pretreated rats. Regul Pept 66:51-54.
22. Muratani H, Averill DB, Ferrario CM. 1991. Effect of angiotensin II in the ventrolateral medulla of spontaneously hypertensive rats. Am J Physiol 260:R977-R984.
23. Muratani H, Ferrario CM, Averill DB. 1993. Ventrolateral medulla in spontaneously hypertensive rats: role of angiotensin II. Am J Physiol 264:R388-R395.
24. Nicolaidis S, Ishibashi S, Gueguen B, Thornton SN, De Beaurepaire R. 1983. Iontophoretic investigation of identified SFO angiotensin responsive neurons firing in relation to blood pressure changes. Brain Res Bull 10:357-363.
25. Phillips MI. 1987. Functions of angiotensin in the central nervous system. Annu Rev Physiol 49:413-445.
26. Qadri F, Culman J, Veltmar A, Maas K, Rascher W, Unger T. 1993. Angiotensin II-induced vasopressin release is mediated through alpha-1 adrenoreceptors and angiotensin II AT1 receptors in the supraoptic nucleus. J Pharmacol Exp Ther 267:567-574.
27. Qadri F, Waldmann T, Wolf A, Hohle S, Rascher W, Unger T. 1998. Differential contribution of angiotensinergic and cholinergic receptors in the hypothalamic paraventricular nucleus to osmotically induced AVP release. J Pharmacol Exp Ther 285:1012-1018.
28. 1-receptor antagonism in normal and heart-failed sheep. Am J Physiol 269:H425-H432.
29. Reid IA. 1992. Interactions between ANG II, sympathetic nervous system, and baroreceptor reflexes in regulation of blood pressure. Am J Physiol 262:E763-E778.
30. Robillard JE, Matson JR, Sessions C, Smith FG. 1979. Development aspects of renal tubular reabsorption of water in the lamb fetus. Pediatr Res 13:1172-1176.
31. Rowland NE. 1998. Brain mechanisms of mammalian fluid homeostasis: insights from use of immediate early gene mapping. Neuroscibiobehav Rev 23:49-63.
32. Rowland NE, Li BH, Rozelle AK, Smith GC. 1994. Comparison of fos-like immunoreactivity induced in rat brain by central injection of angiotensin II and carbachol. Am J Physiol 267:R792-R798.
33. Segura BJ, Zhang WZ, Xiao LQ, Logsdon CD, Mulholland MW. 2005. Sphingosine-1-phosphate induces early response gene expression in C6 glioma cells. Mol Brain Res 133:325-328.
34. Sesoko S, Muratani H, Takishita S, Teruya H, Kawazoe N, Fukiyama K. 1995. Modulation of the baroreflex function by angiotensin II endogenous to the caudal ventrolateral medulla. Brain Res 671:38-44.
35. Sharp FR, Sagar SM, Hicks K, Lowenstein D, Hisanaga K. 1991. c-fos mRNA, Fos, and Fos-related antigen induction by hypertonic saline and stress. J Neurosci 11:2321-2331.
36. Shi L, Hu F, Morrissey P, Yao J, Xu Z. 2003. Intravenous angiotensin induces brain c-fos expression and vasopressin release in the near-term ovine fetus. Am J Physiol 285:E1216-E1222.
37. Shi L, Guerra C, Yao J, Xu Z. 2004a. Vasopressin mechanism-mediated pressor responses caused by central angiotensin II in the ovine fetus. Pediatr Res 56:756-762.
38. Shi L, Koos B, Yao J, Xu Z. 2004b. Induced fetal depressor or pressor responses associated with c-fos by intravenous or intracerebroventricular losartan. Brain Res Dev Brain Res 153:53-60.
39. Stadler T, Veltmar A, Qadri F, Unger T. 1992. Angiotensin II evokes noradrenaline release from the paraventricular nucleus in conscious rats. Brain Res 569:117-122.
40. Steckelings VM, Bottari SP, Unger T. 1992. Angiotensin receptor subtypes in the brain. Trends Pharmacol Sci 13:365-368.
41. Streeten DHP, Anderson GH Jr. 1984. Angiotensin-receptor blocking drugs. In: Doyle AE, editor. Handbook of hypertension, vol. 5. Clinical pharmacology of antihypertensive drugs. Amsterdam: Elsevier. p 246-271.
42. Sugawara AM, Vendramini RC, Barbosa SP, Brunetti IL, Menani JV, De Luca LA Jr. 2002. Dissociation between the circulating renin-angiotensin system and angiotensin II receptors in central losartan-induced hypertension. Braz J Med Biol Res 35:1069-1074.
43. 1)-receptors, a light and electron microscopic study. Brain Res 1008:224-235.
44. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF. 1991. Nonpeptide angiotensin II receptor antagonists. Trends Pharmacol Sci 12:55-62.
45. Timmermans PBMWM, Wong PC, Chiu AT, Herblin WF, Carini DJ, Lee RJ, Wexler RR, Saye JAM, Smith RD. 1993. Angiotensin II receptor and angiotensin II receptor antagonists. Pharmacol Rev 45:205-251.
46. Weisinger RS, Blair-West JR, Burns P, Denton DA, Tarjan E. 1997. Role of brain angiotensin in thirst and sodium appetite of rats. Peptides 18: 977-984.
47. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ, Wexler RR, Johnson AL, Timmermans PBMWM. 1990. Nonpeptide angiotensin II receptor antagonists. XI. Pharmacology of EXP 3174: an active metabolite of DuP 753, an orally active antihypertensive agent. J Pharmacol Exp Ther 255:211-217.
48. Wong PC, Price WA, Chiu AT, Duncia JV, Carini DJ. 1991. In vivo pharmacology of DuP 753. Am J Hypertens 4:288S-298S.
49. Wright JW, Harding JW. 1992. Regulatory role of brain angiotensins in the control of physiological and behavioral responses. Brain Res Bull 17: 227-262.
50. Xu Z, Calvario G, Yao J, Day L, Ross MG. 2001. Central angiotensin induction of fetal brain c-fos expression and swallowing activity. Am J Physiol 280:R1837-R1843.
51. Xu Z, Shi L, Hu F, White R, Stewart L, Yao J. 2003. In utero development of central ANG-stimulated pressor response and hypothalamic fos expression. Brain Res 145:169-176.
52. Xu Z, Shi L, Yao J. 2004. Central angiotensin II induced pressor responses and neural activity in utero and hypothalamic angiotensin receptors in preterm ovine fetus. Am J Physiol 286:H1507-H1514.
53. Xu Z, Hu F, Shi L, Sun W, Wu J, Morrussey P, Yao J. 2005. Central angiotensin-mediated vasopressin release and activation of hypothalamic neurons in younger fetus at pre-term. Peptides 26:307-314.